ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

³Â¿¡ÍŶӱ¨µÀParkinÒÖÖÆ¾ÞÊÉϸ°û¿¹Ô­µÝ³ÊÔö½øÖ×ÁöÃâÒßÌÓÒݵĻúÖÆ

¸å¼þȪԴ£º£º£ºÖÐɽҽѧԺ ±à¼­£º£º£ºÌ¸Ï£¡¢¡¢¡¢ÎâÁ¢¼á ÉóºË£º£º£ºËïÒ«±ó ÔĶÁÁ¿£º£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±³Â¿¡£¡£¡£©¶ñÐÔÖ×ÁöµÄÃâÒßÖÎÁÆÒòTϸ°û½þÈóȱ·¦ÔÚʵÌåÁöÖÐÊÜÏÞ£¬£¬¶ø¾ÞÊÉϸ°û×÷ΪÖ×Áö΢ÇéÐεĽ¹µã×é·Ö£¬£¬Æä¹¦Ð§µ÷¿Ø³ÉΪҪº¦Í»ÆÆ¿Ú¡£¡£¡£ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ³Â¿¡ÍŶÓǰÆÚ·¢Ã÷°ÐÏò¾ÞÊÉϸ°ûÃâÒß¼ì²éµã£¨ÈçSiglec-9¡¢¡¢¡¢SIRP¦Á£©¿ÉÖØËÜÃâÒßÒÖÖÆÎ¢ÇéÐΣ¨Nature Cancer, 2023; 2024£©¡£¡£¡£Òò´Ë£¬£¬ÖØËܾÞÊÉϸ°ûÖ÷µ¼µÄÃâÒßÒÖÖÆÎ¢ÇéÐΣ¬£¬½«Îª¿ª·¢ÐÂÐÍÃâÒßÁªºÏÁÆ·¨ÌṩÖ÷ÒªÍ»ÆÆ¿Ú¡£¡£¡£

2025Äê3ÔÂ22ÈÕ£¬£¬³Â¿¡ÍŶÓÔÚScience AdvancesÔÚÏß½ÒÏþÁËÌâΪ¡°AMPK-dependent Parkin activation suppresses macrophage antigen presentation to promote tumor progression¡±µÄÑо¿ÂÛÎÄ¡£¡£¡£¸ÃÑо¿Ê×´ÎÕ¹ÏÖÁËÖ×ÁöÏà¹Ø¾ÞÊÉϸ°û£¨TAMs£©ÖеÄParkinͨ¹ýÒÖÖÆ¾ÞÊÉϸ°ûÌá³Ê¿¹Ô­Ôö½øÊµÌåÖ×ÁöÃâÒßÌÓÒݵĹ¦Ð§»úÖÆ£¬£¬ÆÊÎöÁËParkin·Ö×ÓµÄй¦Ð§¡£¡£¡£

¸ÃÑо¿Ê×ÏÈͨ¹ý¹¹½¨¶àÖÖСÊóÖ×ÁöÄ£×Ó£¬£¬·¢Ã÷ParkinÇóýСÊó£¨Park2-/-£©¿ÉÏÔÖøÒÖÖÆÖ×ÁöÉú³¤¡£¡£¡£½øÒ»²½¾ÙÐе¥Ï¸°ûת¼×é²âÐòÆÊÎö¡¢¡¢¡¢Á÷ʽϸ°ûÊõ¼°TCR²âÐò£¬£¬²¢¹¹½¨ÁËParkin¾ÞÊÉϸ°ûÌõ¼þÐÔÇóýСÊó£¨Park2fl/fl-Lyz2-Cre+/-£©£¬£¬¸ÃÑо¿·¢Ã÷Parkin ÇóýÔöÇ¿ÁËTAMsÖÐMHC-I±í´ïºÍ¿¹Ô­µÝ³Ê£¬£¬½ø¶øÔö½øTϸ°ûµÄ»î»¯¡¢¡¢¡¢TCRÀ©Ôö¡¢¡¢¡¢Ï¸°ûÔöÖ³¼°½þÈ󣬣¬´Ó¶ø¿ØÖÆÖ×ÁöÏ£ÍûÓ븴·¢¡£¡£¡£Í¨¹ý¶Ô»úÖÆµÄ̽Ë÷£¬£¬Ñо¿Õß¹¹½¨ÁËParkinÂѰ׵ãÍ»±äµÄ¾ÞÊÉϸ°û¼°¾ÞÊÉϸ°û×ÔÊÉȱÏݵÄÌõ¼þÐÔÇóýСÊó£¨Atg5fl/fl-Lyz2-Cre+/-£©£¬£¬Ã÷È·ÁËTAMsÖÐAMPK ¼¤»îParkinµÄE3·ºËØÅþÁ¬Ã¸»îÐÔ£¬£¬µ÷¿ØATG5ÒÀÀµÐÔµÄ×ÔÊÉ×÷ÓÃϵ÷¾ÞÊÉϸ°û MHC-IµÄ±í´ï£¬£¬µ¼Ö³ʵÝÖ×Áö¿¹Ô­È±·¦£¬£¬Ï÷ÈõÁË¿¹Ö×ÁöÃâÒß·´Ó³¡£¡£¡£

ÖÎÁÆÕ½ÂÔ·½Ã棬£¬¸ÃÑо¿·¢Ã÷ParkinÇóýµÄ¾ÞÊÉϸ°û¹ý¼Ì»ØÊä¿ÉÒÖÖÆÃâÒßȱÏÝСÊóµÄÖ×ÁöÏ£Íû£¬£¬Åú×¢Æä×ÔÁ¦ÓÚTϸ°ûʩչ¿¹Ö×Áö×÷Óᣡ£¡£ÁªºÏPD-L1µ¥¿¹ÖÎÁÆ¿ÉЭͬÔöÇ¿ÁÆÐ§£¬£¬ÌáÐѰÐÏòParkinµÄϸ°ûÖÎÁƾßÓÐת»¯Ç±Á¦¡£¡£¡£¸ÃÑо¿Îª¿ª·¢»ùÓÚ¾ÞÊÉϸ°û¿¹Ô­Ìá³ÊµÄÐÂÐÍÃâÒßÁÆ·¨ÌṩÁËÀíÂÛÒÀ¾Ý¡£¡£¡£

×ÛÉÏËùÊö£¬£¬¸ÃÑо¿ÆÊÎöÁËAMPK ¼¤»îParkinͨ¹ýATG5ÒÀÀµÐÔµÄ×ÔÊÉ×÷ÓÃϵ÷¾ÞÊÉϸ°û MHC-IµÄ±í´ï£¬£¬Ï÷ÈõÁ˾ÞÊÉϸ°û¶ÔÖ×Áö¿¹Ô­³ÊµÝ£¬£¬½ø¶øÒÖÖÆÁË¿¹Ö×ÁöÃâÒß·´Ó³£¨Í¼1£©¡£¡£¡£Õ¹ÏÖÁËParkin×÷Ϊ¾ÞÊÉϸ°û¿¹Ô­µÝ³ÊÒÖÖÆÒò×ÓµÄй¦Ð§£¬£¬Æä°ÐÏòÕ½ÂÔÄܹ»Ôö½ø¾ÞÊÉϸ°û»î»¯Tϸ°û´Ó¶ø·´¿¹ÃâÒßÌÓÒÝ¡£¡£¡£

57408CAFB4CE7910700F28996DD_DF4C81FF_16591

ͼ1. »úÖÆÊ¾Òâͼ

ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ²©Ê¿ºóÍõܰÓï¡¢¡¢¡¢²©Ê¿½áÒµÉúÀîܲÒÝΪ¸ÃÂÛÎÄÅäºÏµÚÒ»×÷Õß¡£¡£¡£³Â¿¡½ÌÊÚ¡¢¡¢¡¢¹ãÖÝÒ½¿Æ´óѧÁξ²½ÌÊÚ¼°²©Ê¿ºóÍõܰÓïΪÂÛÎĵÄÅäºÏͨѶ×÷Õß¡£¡£¡£

¸ÃÑо¿»ñµÃ¿Æ¼¼²¿ÖصãÑз¢ÏîÄ¿¡¢¡¢¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԭ´´Ì½Ë÷ÏîÄ¿¼°ÃæÉÏÏîÄ¿ºÍÇàÄêÏîÄ¿¡¢¡¢¡¢¹ã¶«Ê¡¡°Öé½­È˲ÅÍýÏ롱µÈÏîÄ¿×ÊÖú¡£¡£¡£¸ÃÑо¿»ñµÃngµç×ÓÓÎÏ·Ö£ÀûÃñ½ÌÊÚ¡¢¡¢¡¢²ÌÎÀ±ó½ÌÊÚ£¬£¬ËÄ´¨Ê¡Ö×ÁöҽԺŷ¾ê¾ê½ÌÊÚ£¬£¬°Ä´óÀûÑÇÀ¥Ê¿À¼´óѧÓàµÏ½ÌÊÚ£¬£¬¼°¼ÓÄôóÂ󼪶û´óѧEdward Fon½ÌÊÚ¡¢¡¢¡¢Jean-Fran?ois Trempe½ÌÊڵĴóÁ¦Ð­Öú¡£¡£¡£¶¯ÎïʵÑéÒÀÍÐÓÚngµç×ÓÓÎϷʵÑ鶯ÎïÖÐÐÄÍê³É¡£¡£¡£ngµç×ÓÓÎϷΪÂÛÎĵÚÒ»µ¥Î»¡£¡£¡£

Ô­ÎÄÁ´½Ó£º£º£ºhttps://www.science.org/doi/10.1126/sciadv.adn8402



ÎĸåÖÕÉ󣺣º£ººÂÑžê

¡¾ÍøÕ¾µØÍ¼¡¿